Cyclic changes in the matrix metalloproteinase system in the ovary and uterus.
With each estrous or menstrual cycle, extensive alterations occur in the extracellular matrix and connective tissue of the ovary and uterus. In the ovary, these changes occur during follicular development, breakdown of the follicular wall and extrusion of the oocyte, as well as during the formation and regression of the corpus luteum. In the uterus, the endometrium undergoes dramatic connective tissue turnover associated with tissue breakdown and subsequent regrowth during each menstrual cycle. These changes in the ovarian and uterine extracellular architecture are regulated, in part, by the matrix metalloproteinase (MMP) system. This system is comprised of both a proteolytic component, the MMPs, and associated inhibitors, and it is involved in connective tissue remodeling processes throughout the body. The current review highlights the key features of the MMP system and focuses on the changes in the MMPs and the tissue inhibitors of metalloproteinases during the dynamic remodeling that takes place in the ovary and uterus during the estrous and menstrual cycles.
Curry
T E
TE
Department of Obstetrics and Gynecology, University of Kentucky, Lexington, Kentucky 40536-0293, USA. tecurry@pop.uky.edu
Osteen
K G
KG
D000818:Animals; D003338:Corpus Luteum / Q000502:physiology; D004971:Estrus; D005260:Female; D006801:Humans; D020782:Matrix Metalloproteinases / Q000378:metabolism*; D008597:Menstrual Cycle; D006080:Ovarian Follicle / Q000502:physiology; D010053:Ovary / Q000201:enzymology*; D019714:Tissue Inhibitor of Metalloproteinases / Q000378:metabolism; D014599:Uterus / Q000201:enzymology*
D019714:Tissue Inhibitor of Metalloproteinases; D020782:Matrix Metalloproteinases